Divalproex Sodium Tablet, Film Coated, Extended Release
NDC Package 68084-310-01
Package Information
Divalproex Sodium tablets is a medication used to treat seizure disorders, certain psychiatric conditions (manic phase of bipolar disorder), and to prevent migraine headaches. This formulation utilizes a tablet, film coated, extended release delivery system. Marketed by American Health Packaging, this product is identified by NDC 68084-310 and is authorized under FDA application ANDA078239.
Identification & Billing
- RxCUI: 1099563 - divalproex sodium 250 MG 24HR Extended Release Oral Tablet
- RxCUI: 1099563 - 24 HR divalproex sodium 250 MG Extended Release Oral Tablet
- RxCUI: 1099563 - divalproex sodium 250 MG 24 HR Extended Release Oral Tablet
- RxCUI: 1099569 - divalproex sodium 500 MG 24HR Extended Release Oral Tablet
- RxCUI: 1099569 - 24 HR divalproex sodium 500 MG Extended Release Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 68084 - American Health Packaging
- 68084-310 - Divalproex Sodium
- 68084-310-01 - 100 BLISTER PACK in 1 BOX, UNIT-DOSE / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (68084-310-11)
- 68084-310 - Divalproex Sodium
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68084-310-01 identifies a specific commercial package of 100 blister pack in 1 box, unit-dose / 1 tablet, film coated, extended release in 1 blister pack (68084-310-11) of Divalproex Sodium, a human prescription drug labeled by American Health Packaging. This tablet, film coated, extended release is formulated for oral use and contains divalproex sodium as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by American Health Packaging on November 21, 2013.
What are the primary indications for this medication?
This medication is used to treat seizure disorders, certain psychiatric conditions (manic phase of bipolar disorder), and to prevent migraine headaches. It works by restoring the balance of certain natural substances (neurotransmitters) in the brain.
How is this American Health Packaging product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68084031001. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.